Welcome to our dedicated page for Celanese Del news (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese Del stock.
Celanese Corp Del (CE) delivers essential chemical solutions and specialty materials powering industries from automotive to electronics. This dedicated news hub provides investors and professionals with timely updates on corporate developments, financial milestones, and technical innovations.
Access authoritative coverage of earnings announcements, strategic partnerships, and product advancements that shape Celanese's market leadership. Our curated collection features official press releases and third-party analysis of critical initiatives in polymer engineering, cellulose derivatives, and sustainable production methods.
Key updates include financial performance reports, manufacturing capacity expansions, and R&D breakthroughs in high-performance materials. Track the company's progress in addressing evolving demands across global markets while maintaining operational excellence in chemical engineering.
Bookmark this page for streamlined access to Celanese's latest business developments. Stay informed about the specialty materials sector through comprehensive coverage of CE's strategic positioning and industry impact.
Celanese Corporation (NYSE: CE) has announced a significant investment in expanding its capabilities to meet the rising global demand for pharmaceutical-grade polymers. A new 1,000-square-foot cleanroom facility in Edmonton, Alberta, will be dedicated to cryogenic micronization of VitalDose® EVA material. This process aims to enhance drug delivery solutions for various medical conditions, including cancer and retinal disorders. The facility is expected to begin operations by early 2023, further solidifying Celanese's position in the pharmaceutical market.
Celanese Corporation (NYSE: CE) is set to host its third quarter 2022 earnings call on
Celanese Corporation (NYSE: CE) has received a grant from the Bill & Melinda Gates Foundation to develop a refillable contraceptive implant. This project aims to create a functional prototype within 18 months, focusing on enhancing access to contraceptive options for women in low- and middle-income countries. The development will leverage Celanese's VitalDose® drug delivery technology, which has a strong history in women's health. This initiative aligns with Celanese's mission to expand healthcare access globally.
Celanese Corporation (NYSE: CE) reported second quarter 2022 GAAP diluted EPS of $4.03 and adjusted EPS of $4.99, with net sales of $2.5 billion, reflecting a 2% decrease from the prior quarter but a 13% increase year-over-year. The company successfully offset supply interruptions and inflation, achieving an operating profit of $483 million. Record sales in Engineered Materials reached $948 million. The firm secured $10.5 billion in financing for the DuPont M&M acquisition. However, they anticipate softening demand and expect adjusted EPS of $4.00 to $4.50 for Q3.
Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share on common stock, payable on August 8, 2022. This dividend is designated for shareholders of record as of July 25, 2022. With a strong presence in the chemical industry, Celanese reported net sales of $8.5 billion in 2021, showcasing its robust financial health and commitment to delivering value to shareholders.
Celanese Corporation (NYSE: CE) has priced an additional €1.5 billion in permanent financing to acquire a majority of DuPont’s Mobility & Materials business. This brings the total secured financing for the acquisition to $10.5 billion at an effective net borrowing rate of approximately 5.4%. The new euro notes feature maturities of 4 and 6.5 years, with interest rates of 4.78% and 5.34%. Celanese aims to optimize its debt profile, increase flexibility, and potentially reduce borrowing costs through future cross-currency swaps.
Celanese Corporation (NYSE: CE) has priced
Celanese Corporation (NYSE: CE) will host a conference call on July 29, 2022, at 10:00 a.m. ET to discuss its Q2 2022 earnings. The earnings press release will be distributed on July 28, 2022, after market close. Investors can access the call via webcast or dial in at 1-877-407-0989 (international: 1-201-389-0921). A replay will be available on demand from July 29 to August 12, 2022. Celanese had $8.5 billion in net sales in 2021, employing around 8,500 people globally.
Celanese Corporation (NYSE: CE) has announced an immediate increase in list and off-list selling prices for various acetyl intermediate products. Prices for Acetic Acid and Acetic Anhydride will rise to $100/MT, Vinyl Acetate Monomer to $200/MT, Ethyl Acetate/Butyl Acetate to $50/MT, VAE Emulsions to $100/MT, and Redispersable Powders to $150/MT. The adjustments are applicable as contracts allow and are incremental to previous increases. Celanese continues to leverage its global chemistry to deliver value across industries.
Celanese Corporation (NYSE: CE) has declared a force majeure for its Acetyl Chain and Acetate Tow products due to unforeseen interruptions in raw material supply, particularly affecting the Texas Gulf Coast. Affected products include
- Acetic acid
- Vinyl acetate monomer (VAM)
- Ethyl acetate
- Acetic anhydride
- Vinyl and acrylic emulsions
- Redispersible powders
- Acetate tow